Clinical Trial Update: Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing genotyping-guided use of triflusal versus clopidogrel for secondary prevention after ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Triflusal (triflusal)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Cerebral Infarction | Phase 4 | Status: COMPLETED